×
About 143 results

ALLMedicine™ Diffuse Large Cell Lymphoma Center

Research & Reviews  67 results

Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiat...
https://doi.org/10.1080/10428194.2020.1864353
Leukemia & Lymphoma; Dabaja BS, Milgrom SA et. al.

Dec 28th, 2020 - Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiation therapy to improve outcomes.|2020|Dabaja BS,Milgrom SA,Wirth A,|

Increased CD200 expression in post-transplant lymphoproliferative disorders correlates ...
https://doi.org/10.1016/j.anndiagpath.2020.151585
Annals of Diagnostic Pathology; Vaughan JW, Shi M et. al.

Aug 23rd, 2020 - CD200 is a membrane protein with immunosuppressive function and is expressed in many hematopoietic neoplasms, including acute myeloid leukemia (AML), plasma cell myeloma (PCM), and B-cell lymphoproliferative disorders, but is mostly negative in di...

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CA...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316220
Blood Schöder H, Polley MC et. al.

Apr 1st, 2020 - As part of a randomized, prospective clinical trial in large cell lymphoma, we conducted serial fluorodeoxyglucose positron emission tomography (FDG-PET) at baseline, after 2 cycles of chemotherapy (interim PET [i-PET]), and at end of treatment (E...

Diffuse Large Cell Lymphoma
https://emedicine.medscape.com/article/202969-overview

Jun 11th, 2019 - Practice Essentials Diffuse large cell lymphoma (see the image below) is the most common lymphoma, representing 31% of the non-Hodgkin lymphomas (NHLs), and it is rapidly fatal if untreated. Treatment recommendations and prognosis vary with differ...

Diffuse Large Cell Lymphoma 
https://emedicine.medscape.com/article/202969-print

Jun 11th, 2019 - Practice Essentials Diffuse large cell lymphoma (see the image below) is the most common lymphoma, representing 31% of the non-Hodgkin lymphomas (NHLs), and it is rapidly fatal if untreated. Treatment recommendations and prognosis vary with differ...

see more →

Guidelines  1 results

POLIVY™ (polatuzumab vedotin) - Official Physician Site‎
https://www.polivy.com/hcp.html

Learn About Now Approved POLIVY™ & See If Treatment Is Right For Your Patients. Prescribing Information. Safety Information. Patient Financial Support. Clinical Trial Results. Types: Dosing and Administration, Warnings and Precautions, Contraindic...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  71 results

Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiat...
https://doi.org/10.1080/10428194.2020.1864353
Leukemia & Lymphoma; Dabaja BS, Milgrom SA et. al.

Dec 28th, 2020 - Secondary central nervous system diffuse large cell lymphoma: an opportunity for radiation therapy to improve outcomes.|2020|Dabaja BS,Milgrom SA,Wirth A,|

Increased CD200 expression in post-transplant lymphoproliferative disorders correlates ...
https://doi.org/10.1016/j.anndiagpath.2020.151585
Annals of Diagnostic Pathology; Vaughan JW, Shi M et. al.

Aug 23rd, 2020 - CD200 is a membrane protein with immunosuppressive function and is expressed in many hematopoietic neoplasms, including acute myeloid leukemia (AML), plasma cell myeloma (PCM), and B-cell lymphoproliferative disorders, but is mostly negative in di...

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CA...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316220
Blood Schöder H, Polley MC et. al.

Apr 1st, 2020 - As part of a randomized, prospective clinical trial in large cell lymphoma, we conducted serial fluorodeoxyglucose positron emission tomography (FDG-PET) at baseline, after 2 cycles of chemotherapy (interim PET [i-PET]), and at end of treatment (E...

Diffuse Large Cell Lymphoma
https://emedicine.medscape.com/article/202969-overview

Jun 11th, 2019 - Practice Essentials Diffuse large cell lymphoma (see the image below) is the most common lymphoma, representing 31% of the non-Hodgkin lymphomas (NHLs), and it is rapidly fatal if untreated. Treatment recommendations and prognosis vary with differ...

Diffuse Large Cell Lymphoma 
https://emedicine.medscape.com/article/202969-print

Jun 11th, 2019 - Practice Essentials Diffuse large cell lymphoma (see the image below) is the most common lymphoma, representing 31% of the non-Hodgkin lymphomas (NHLs), and it is rapidly fatal if untreated. Treatment recommendations and prognosis vary with differ...

see more →

News  3 results

POLIVY™ (polatuzumab vedotin) - Official Physician Site‎
https://www.polivy.com/hcp.html

Learn About Now Approved POLIVY™ & See If Treatment Is Right For Your Patients. Prescribing Information. Safety Information. Patient Financial Support. Clinical Trial Results. Types: Dosing and Administration, Warnings and Precautions, Contraindic...

Spontaneous Remission in Diffuse Large Cell Lymphoma
https://www.staging.medscape.com/viewarticle/910051

Abstract and Introduction Abstract Background: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission ...

Spontaneous Remission in Diffuse Large Cell Lymphoma
https://www.medscape.com/viewarticle/910051

Abstract and Introduction Abstract Background: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission ...

see more →